So kind of to answer your question, so the next steps that we're looking at is continuing to re-franchise clinics. As we do that, we'll see some pretty big reductions in big categories like salaries and wages, employee benefits, insurance. If you think about workers' comp insurance, big reduction with fewer employees. And then other things like legal fees and travel and some other expenses.
Nov 6, 2025 / receipt, needs a key / Sanjeev Razan, CEO | earnings call 2025-11-06 | transcript 11b4391a-b52f-4786-9a2a-289232adc4bf | chars 27673-28066 | segment 27
From the payroll side, from other categories like insurance and software costs and legal fees and travel. So there's quite a few line items that we're taking a look at. Being careful not to cut too soon, but to identify what the opportunity is. And then over time, tightening up with those expense line items as we continue to transition.
Aug 7, 2025 / receipt, needs a key / Nick Sherwood, other | earnings call 2025-08-07 | transcript bd97e22b-7766-4b47-9f7c-797ff46e266b | chars 26588-26926 | segment 27
Minimum term commitment on plans changed from 2 to 3 months
ir_statement / Sep 16, 2026 / receipt
Rolled out enhanced pricing structure in approximately 300 clinics with the rest of the portfolio planned to begin in early Q3
ir_statement / Sep 16, 2026 / receipt
disciplined cost management
ir_statement / Sep 16, 2026 / receipt
our reiterated 2026 guidance for system-wide sales, system-wide comp sales, consolidated Adjusted EBITDA, and new franchised clinic openings
ir_statement / Sep 16, 2026 / receipt
tightening our operating structure across the system
ir_statement / Sep 16, 2026 / receipt
disciplined cost management
ir_statement / Sep 16, 2026 / receipt
our reiterated 2026 guidance for system-wide sales, system-wide comp sales, consolidated Adjusted EBITDA, and new franchised clinic openings
ir_statement / Sep 16, 2026 / receipt
tightening our operating structure across the system
ir_statement / Sep 16, 2026 / receipt
Continued focus on cost discipline across operations
ir_statement / Sep 16, 2026 / receipt
Optimizing capital allocation
ir_statement / Sep 16, 2026 / receipt
Potential entry into first international markets
ir_statement / Sep 16, 2026 / receipt
B2B partnership program
ir_statement / Sep 16, 2026 / receipt
| Bret Sanders | director | - | receipt |
| Jake Singleton | Chief Financial Officer | - | receipt |
| John P. Meloun | Chief Financial Officer | - | receipt |
| Peter Holt | Chief Executive Officer | - | receipt |
| Richard A. Kerley | director | - | receipt |
| Sanjeev Razan | CEO | - | receipt |
| Sanjeev Razdan | CEO | - | receipt |
| Scott Bowman | CFO | - | receipt |
| 2024-10-15 | President and Chief Executive Officer, appointed | sec_8k |
| 2024-10-15 | President and Chief Executive Officer, departed | sec_8k |
| 2018-11-08 | Chief Financial Officer, appointed | sec_8k |
| 2018-08-09 | Chief Financial Officer, departed | sec_8k |
| 2018-06-21 | Chief Financial Officer, departed | sec_8k |
| 2016-11-10 | Chief Financial Officer, appointed | sec_8k |
| 2016-08-11 | Chief Executive Officer, appointed | sec_8k |
| 2016-06-23 | Chief Financial Officer, departed | sec_8k |
| 2016-05-03 | Chief Operating Officer, appointed | sec_8k |
| 2015-09-18 | director, appointed | sec_8k |
| 2015-04-17 | director, appointed | sec_8k |